Literature DB >> 1924147

Dodecyl N,N-dimethylamino acetate and azone enhance drug penetration across human, snake, and rabbit skin.

J Hirvonen1, J H Rytting, P Paronen, A Urtti.   

Abstract

The effectiveness of the penetration enhancers, dodecyl N,N-dimethylamino acetate (DDAA) and Azone, on pretreated human epidermis for the permeation of model drugs, indomethacin, 5-fluorouracil, and propranolol-HCl, was studied in in vitro diffusion cells. Snakeskin (Elaphe obsoleta) and rabbit pinna skin were compared as possible models for human skin. The drug concentrations were analyzed by HPLC. With all skins and all model drugs, DDAA increased drug permeability at least as well as Azone, and in most cases it was a more effective permeation enhancer. The relative permeation improvements in human skin, snakeskin, and rabbit skin were 10- to 20-, 5- to 50-, and 20- to 120-fold, respectively. Tritiated water served as an indicator of skin condition. Its penetration in the skin samples was independent of the drugs used, and both penetration enhancers significantly increased the flux of tritiated water through all skins. Thus, DDAA and Azone significantly increased the permeation of lipophilic and hydrophilic model compounds. Rabbit pinna skin was a poor model for human skin in vitro, while snakeskin was much closer to human skin in terms of transdermal permeability. In most cases drug permeability decreased in the order rabbit much greater than human greater than or less than snake.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924147     DOI: 10.1023/a:1015824100788

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Dose-dependent enhancement effects of azone on skin permeability.

Authors:  W J Lambert; W I Higuchi; K Knutson; S L Krill
Journal:  Pharm Res       Date:  1989-09       Impact factor: 4.200

2.  Facilitated transport of basic and acidic drugs in solutions through snakeskin by a new enhancer--dodecyl N,N-dimethylamino acetate.

Authors:  C Fleeker; O Wong; J H Rytting
Journal:  Pharm Res       Date:  1989-06       Impact factor: 4.200

3.  Corneal penetration behavior of beta-blocking agents I: Physiochemical factors.

Authors:  R D Schoenwald; H S Huang
Journal:  J Pharm Sci       Date:  1983-11       Impact factor: 3.534

4.  Effect of the absorption enhancer, Azone, on the transport of 5-fluorouracil across hairless rat skin.

Authors:  K Sugibayashi; K Hosoya; Y Morimoto; W I Higuchi
Journal:  J Pharm Pharmacol       Date:  1985-08       Impact factor: 3.765

5.  Transdermal controlled delivery of propranolol from a multilaminate adhesive device.

Authors:  M Corbo; J C Liu; Y W Chien
Journal:  Pharm Res       Date:  1989-09       Impact factor: 4.200

Review 6.  Cutaneous pharmacokinetics: 10 steps to percutaneous absorption.

Authors:  R C Wester; H I Maibach
Journal:  Drug Metab Rev       Date:  1983       Impact factor: 4.518

7.  Shed snake skin and hairless mouse skin as model membranes for human skin during permeation studies.

Authors:  P C Rigg; B W Barry
Journal:  J Invest Dermatol       Date:  1990-02       Impact factor: 8.551

8.  Enhanced percutaneous penetration with 1-dodecylazacycloheptan-2-one.

Authors:  R B Stoughton
Journal:  Arch Dermatol       Date:  1982-07

9.  omega-Hydroxyacid derivatives in the epidermis of several mammalian species.

Authors:  P W Wertz; D T Downing
Journal:  Comp Biochem Physiol B       Date:  1989

10.  New alkyl N,N-dialkyl-substituted amino acetates as transdermal penetration enhancers.

Authors:  O Wong; J Huntington; T Nishihata; J H Rytting
Journal:  Pharm Res       Date:  1989-04       Impact factor: 4.200

  10 in total
  10 in total

1.  Physical and chemical enhancement of transdermal delivery of triptorelin.

Authors:  S Nicoli; S Rimondi; P Colombo; P Santi
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

2.  Ionized prodrugs of dehydroepiandrosterone for transdermal iontophoretic delivery.

Authors:  S Laneri; A Sacchi; E A di Frassello; E Luraschi; P Colombo; P Santi
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

3.  Electrochemical characterization of human skin by impedance spectroscopy: the effect of penetration enhancers.

Authors:  K Kontturi; L Murtomäki; J Hirvonen; P Paronen; A Urtti
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

4.  Synthesis and enhancing effect of dodecyl 2-(N,N-dimethylamino)propionate on the transepidermal delivery of indomethacin, clonidine, and hydrocortisone.

Authors:  S Büyüktimkin; N Büyüktimkin; J H Rytting
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

5.  Effect of some penetration enhancers on epithelial membrane lipid domains: evidence from fluorescence spectroscopy studies.

Authors:  T M Turunen; A Urtti; P Paronen; K L Audus; J H Rytting
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

6.  Percutaneous absorption of 2',3'-dideoxyinosine in rats.

Authors:  E Mukherji; N J Millenbaugh; J L Au
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

7.  A novel hydrophilic adhesive matrix with self-enhancement for drug percutaneous permeation through rat skin.

Authors:  Jianhua Zhang; Zhipeng Liu; Hai Du; Yong Zeng; Liandong Deng; Jinfeng Xing; Anjie Dong
Journal:  Pharm Res       Date:  2009-02-19       Impact factor: 4.200

8.  Microdialysis sampling for the investigation of dermal drug transport.

Authors:  J M Ault; C E Lunte; N M Meltzer; C M Riley
Journal:  Pharm Res       Date:  1992-10       Impact factor: 4.200

Review 9.  Current Status of Amino Acid-Based Permeation Enhancers in Transdermal Drug Delivery.

Authors:  Rui Pereira; Sandra G Silva; Marina Pinheiro; Salette Reis; M Luísa do Vale
Journal:  Membranes (Basel)       Date:  2021-05-07

10.  Evaluation of EMLA cream for preventing pain during tattooing of rabbits: changes in physiological, behavioural and facial expression responses.

Authors:  Stephanie C J Keating; Aurelie A Thomas; Paul A Flecknell; Matthew C Leach
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.